Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial - de Bono, J S; Oudard, S; Ozguroglu, M (Lancet (London, England), 2010)
. doi:10.1016/s0140-6736(10)61389-x